.webp)
ValConnect Innovation Day Princeton: A Glimpse into the Digital Future of Life Sciences
ValConnect Innovation Day Princeton brought Bayer, GSK, Cardinal Health, Transcat & Hansa Biopharma together to explore AI & Smart GxP™ in life sciences.
Latest News
A new Approach for Biosimilarity Assessments: a ValGenesis Story
Apr 20, 2023 9:52:50 AM | This a story about how we helped a company with their biosimilarity assessments and to avoid massive time-to-market delay!
Posts about Generics and Biopharmaceuticals:
A new Approach for Biosimilarity Assessments: a ValGenesis Story
This a story about how we helped a company with their biosimilarity assessments and to avoid massive time-to-market delay!
Comparability for Post-Approval Changes
Today we want to take a fresh look into comparability for post-approval changes. How? We're thinking of a unique multiparametric approach.
Bioequivalence Studies: How to Streamline Generic Drug Approval Process
This blog post will give you an overview of bioequivalence studies and some strategies to streamline your generic drug approval process.
Challenges on Comparability Studies on Early Development Stages
This blog post goes over the key aspects of developing solid comparability studies on early development stages.
Biosimilars Approval: how to Reduce Time to Market?
In this blog post, we tell what the most effective approach for your biosimilars approval to reduce its time to market is.
How to Support Global Manufacturing of Pharma Products
Process, product performance and comparability are key to global production. This is how to support global manufacturing of pharma products.
All Tags
Root-Cause Analysis
Finding the Root Cause in mAB Production: a ValGenesis Story
Learn how we helped a customer find the root cause of a problem in monoclonal antibody (mAB) production and become stronger.
Written by
Sofia Santos
Process Digitalization
How to Accelerate Process Scale-Up With Effective Tech Transfer
There's a need to accelerate pharma product development and process scale-up. Having an effective tech transfer strategy can help you.
Written by
Sofia Santos
Quality Risk Management
Risk and Data as Knowledge Enablers: a Lifecycle Approach - ValGenesis
Read the industry insight on the topic of Quality Risk Management
Presented by
Sandra Silva
CSV and the Shift to CSA
CSA flips the paradigm of traditional CSV to "right-size" validation processes. Learn more about the benefits and principles of the CSA approach, which encourages critical thinking and automation.
Previously
The Benefits of Automating Your Requirements Traceability Matrix
Catalent's Journey of Continuous Improvement for CSV Excellence
Cleaning Validation
Learn how digitization offers a consistent way to carry out cleaning validation lifecycle activities, ensuring your methods and procedures are risk-based and rooted in scientific evidence.
.webp)
Digital Cleaning Validation: From Lifecycle Control to Real-Time Assurance
Discover how digital cleaning validation software like ValGenesis iClean™ is enhancing compliance and operational efficiency in the pharma industry.
Previously
Risk-Based Cleaning Validation: A Lifecycle Approach to Compliance and Efficiency
Pharma 4.0
Waves of new technology and thinking — IoT, AR, cloud, Agile — are transforming the very foundation of validation processes. Learn how to leverage them in a Pharma 4.0 world.
Catalent's Journey of Continuous Improvement for CSV Excellence
Learn how Catalent scaled CSV compliance with ValGenesis VLMS to enhance global IT operations.
Previously
Validating Pharma 4.0 for Smart Manufacturing
The X Factor for Successful Digital Transformation in BioPharma: People
High-quality Content Straight to Your Inbox!
Join our newsletter to receive updates on the latest news and industry-related content tailored to your preferences.
